-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623.P1.54 623. Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Poster I

Symposia: Mantle Cell, Follicular, Waldenstrom's, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Martin Dreyling, MD1, Jiri Mayer, MD2, David Belada, MD, PhD3, Yuqin Song, MD4, Wojciech Jurczak, MD, PhD5, Jonas Paludo, MD6, Michael P. Chu, MD7, Iryna Kryachok, MD8*, Laura Maria Fogliatto, MD9*, Chan Y. Cheah, MBBS DMSc10, Marta Morawska, MD, PhD11,12*, Juan-Manuel Sancho, MD, PhD13*, Yufu Li, MD14*, Caterina Patti, MD15*, Cecily Forsyth, MD16, Jingyang Zhang, PhD17*, Robin Lesley, PhD17*, Safaa Ramadan, MD, PhD18*, Simon Rule, MD19* and Michael Wang, MD20

1Medizinische Klinik III, Klinikum der Universitaet Munchen, Muenchen, Germany
2Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
34th Department of Internal Medicine – Haematology, Charles University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic
4Key Laboratory of Carcinogenesis and Translational Research, Department of Lymphoma, Peking University Cancer Hospital, Beijing, China
5Department of Clinical Oncology, Malopolskie Centrum Medyczne S.C, Krakow, Poland
6Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
7Department of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
8Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine
9Department of Clinical Hematology, Hospital das Clínicas de Porto Alegre, Porto Alegre, Brazil
10Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
11Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland
12Hematology Department, St. John’s Cancer Center, Lublin, Poland
13Clinical Hematology Department, ICO-IJC-Hospital Germans Trias i Pujol, Badalona, Spain
14Department of Hematology, Henan Cancer Hospital, Zheng Zhou, China
15Oncohematology Unit, A.O.O.R. Villa Sofia Cervello, Palermo, Italy
16Central Coast Haematology, North Gosford, Australia
17AstraZeneca, South San Francisco, CA
18AstraZeneca, Cambridge, United Kingdom
19Executive Director, Haematology R&D, AstraZeneca, Cambridge, United Kingdom
20Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Joshua Brody, MD1*, Lorenzo Falchi, MD2, Umberto Vitolo, MD3, Marcel Nijland, MD, PhD4*, Fritz Offner, MD, PhD5, Sylvia Snauwaert, MD, PhD6*, Poliana Patah, MD, PhD7*, Jennifer Marek8*, Christopher Morehouse, MS8*, Andrew J. Steele, PhD8*, Yi Hao, DrPH8*, Daniela Hoehn, MD, PhD8* and Kim Linton9*

1Icahn School of Medicine at Mount Sinai, New York, NY
2Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Candiolo Cancer Institute, FPO-IRCCS, Candiolo (Turin), Italy
4University Medical Center Groningen and University of Groningen, Groningen, Netherlands
5Universitair Ziekenhuis Gent, Gent, Belgium
6Department of Hematology, AZ Sint-Jan Hospital, Bruges, Belgium
7AbbVie, North Chicago, IL
8Genmab, Plainsboro, NJ
9The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom

Stefano Luminari1, Jose C. Villasboas Bisneto, MD2, Geoffrey Chong3*, David Tucker4, Srikanth Ambati5, Chinjune Lin5, Hesham Mohamed5, C. Akunna Otele5*, Giovanni Antico5* and Ana Jiménez Ubieto6*

1Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy
2Mayo Clinic, Rochester, MN
3Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Heidelberg, VIC, Australia
4Haematology Department, Royal Cornwall Hospital, Truro, United Kingdom
5Regeneron Pharmaceuticals, Inc., Tarrytown, NY
6Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain

Patrizia Mondello, MD, PhD, MSc1, Brianna J Negaard, MS2*, Andrew L. Feldman, MD3, Brian K. Link, MD4*, Carla Casulo, MD5, Dai Chihara, MD, PhD6, David A Russler-Germain, MD, PhD7, Jason Romancik8*, Caitlin Gribbin, MD9*, Sara Haddadi10*, Eric Mou, MD4*, Ivana N. Micallef1*, Patrick B. Johnston, MD, PhD11*, Anne J. Novak, PhD1, Yucai Wang, MD, PhD1, Rebecca L. King, MD3*, Thomas M. Habermann, MD1, Peter Martin, MD9, Grzegorz S. Nowakowski, MD11, Loretta Nastoupil6*, James R. Cerhan, MD, PhD12, Christopher R. Flowers, MD, MS6, Izidore S. Lossos, MD10, Richard Burack, MD, PhD13, Matthew J. Maurer, DSc2* and Stephen M. Ansell, MD, PhD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
3Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
4Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
5Division of Hematology and Medical Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
7Siteman Cancer Center, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
8Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, Georgia
9Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
10Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
11Mayo Clinic, Rochester, MN
12Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
13Pathology and Laboratory Medicine, University of Rochester, Rochester, NY

Yanan Zhu1*, Yunfei Lv2*, Xingnong Ye2*, Juying Wei2*, Lixia Sheng3*, Ying Lin4*, Xiang Zhang2*, Xuewu Zhang2*, Hongyan Tong2, Jie Jin, M.D.5 and Wen-Juan Yu1*

1The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
2Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China
4The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China
5Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Tycel J. Phillips, MD1, Marek Trněný2, Carmelo Carlo-Stella, MD3, Jan Maciej Zaucha4*, Tomasz Wrobel5*, Fritz Offner, MD, PhD6, Michael J. Dickinson, MBBS, DMedSci7, Monica Tani8*, Michael Crump, MD9*, Nancy L. Bartlett, MD10, Joaquín Martínez-Lopez11*, Paolo Corradini, MD12, Estefania Mulvihill13*, Alessia Bottos, PhD13*, Derrick Kaufman14*, James Relf15*, Fabiola Bene Tchaleu14*, Alexandra Bazeos15*, Linda Lundberg13* and Franck Morschhauser, MD, PhD16

1City of Hope National Medical Center, Duarte, CA
2Charles University, Prague, Czech Republic
3Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy
4Medical University of Gdańsk, Gdańsk, Poland
5Wroclaw Medical University, Wroclaw, Poland
6Universitair Ziekenhuis Gent, Gent, Belgium
7Peter MacCallum Cancer Centre, Melbourne, Australia
8Ospedale Santa Maria delle Croci, Ravenna, Italy
9Princess Margaret Hospital, Toronto, ON, Canada
10Siteman Cancer Center, Washington University, St. Louis, MO
11Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, imas12, Madrid, Spain
12University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
13F. Hoffmann-La Roche Ltd, Basel, Switzerland
14Genentech, Inc., South San Francisco, CA
15Roche Products Ltd, Welwyn, United Kingdom
16Centre Hospitalier Universitaire de Lille, Lille, France

Yuankai Shi1*, Jianliang Yang1*, Yongping Song2*, Keshu Zhou3*, Zhiming Li, PhD, MD4, Mingzhi Zhang, MD5, Hongmei Jing6, Zhen Wang, MD7*, Li Yu8*, Wei Meng9*, Qiying Lu9* and Wenzhi Tian9*

1Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
2Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
3Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
4Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
5The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
6Peking University Third Hospital, Beijing, CHN
7Linyi Cancer Hospital, Linyi, China
8The Second Affiliated Hospital of Nanchang University, Nanchang, China
9ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China

Paolo Lopedote, MD1, Geoffrey Shouse, PhD, DO2, Alexandra Muir, BSN, RN3*, Carly Rolender3*, Peter Sportelli, BS4, Hari Miskin, MSc4*, Lu Chen, PhD5*, Tycel Phillips, MD6* and Alexey Danilov, MD, PhD7

1Department of Hematology and Medical Oncology, City of Hope National Medical Center, Duarte, CA
2City of Hope Cancer Center, Duarte, CA
3City of Hope National Medical Center, Duarte
4TG Therapeutics, Inc., New York, NY
5Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
6Department of Hematology and Oncology, City of Hope, Duarte, CA
7City of Hope Comprehensive Cancer Center, La Canada Flintridge, CA

Wojciech Jurczak, MD, PhD1, Isabelle Fleury, MD, MSc2, Antonio Pinto3*, Sanne Lugthart, MD4*, Omur Gokmen Sevindik, Prof5, Iryna Kryachok, MD6*, Elizabeth Phillips, MD7, Fei Li8, Chan Y. Cheah, MBBS DMSc9, Jing Yang, DMD10*, Yan Xu10*, Siyang Leng, MD, MS10* and Fangfang Lv11*

1Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Malopolskie, Poland
2Hôpital Maisonneuve – Rosemont, Montreal, ON, Canada
3Struttura Complessa Ematologia Oncologica, Napoli, Italy
4University Hospital Bristol NHS Foundation Trust, Bristol, United Kingdom
5Istanbul Medipol University, International School of Medicine, Istanbul, Turkey
6Oncohematology, National Cancer Institute, Ukraine Hemoblastoses of Division of Conservative Methods of Treatment, Kyiv, Ukraine
7The Christie NHS Foundation Trust, Manchester, United Kingdom
8Department of Hematology, Jiangxi Clinical Research Center for Hematologic Disease, Jiangxi Provincial Key Laboratory of Hematological Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang, China;, Nanchang, China
9Linear Clinical Research and Hollywood Private Hospital, Sir Charles Gairdner Hospital and PathWest Laboratory Medicine, Nedlands, Western Australia, Australia
10Merck & Co., Inc., Rahway, NJ
11Fudan University, Shanghai, China

Yuqin Song, MD1, Qingqing Cai, PhD2, Keshu Zhou, MD3*, Ming Jiang4*, Zhengming Jin, M.D.5*, Lei Zhang, PhD, MD6*, Xiuhua Sun7*, Haiyan Yang8*, Lanfang Li9*, Kaiyang Ding10*, Junyuan Qi, MD11*, Hongmei Jing12*, Wei Yang13*, Min Zhou14*, Jun Ma15*, Zhigang Peng16*, Wei Xu17*, Hui Zhou, MD18, Li Yu19*, Yuankai Shi, MD20*, Guohui Cui21*, Zheng Wang22*, Nawei Liu22*, Yejiang Lou, PhD23*, Yue Shen, PhD22*, Yi Chen, PhD24*, Fenlai Tan22* and Jun Zhu, MD25*

1Department of Lymphoma, Peking University Cancer Hospital, BEIJING, China
2Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
3Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
4Cancer Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China
5Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China
6The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
7The Second Hospital of Dalian Medical University, Dalian, China
8Zhejiang Cancer Hospital, Hangzhou, China
9Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
10Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Anhui, China
11State Key Laboratory of Experimental Hematology, National Clinical Research Center for Hematological Disorders, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
12Department of Hematology, Peking University Third Hospital, Beijing, China
13Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
14Department of Medical Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China
15Harbin Institute of Hematology & Oncology, Harbin, China
16The First Affiliated Hospital of Guangxi Medical University, Nanning, China
17Lymphoma Center, Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
18Department of Lymphoma & Hematology, Hunan Cancer Hospital and Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
19The Second Affiliated Hospital of Nanchang University, Nanchang, China
20Cancer Hospital (Institute), CAMS & PUMC, Beijing, China
21Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
22Guangzhou Lupeng Pharmaceutical Co., Ltd., Guangzhou, China
23Guangzhou Lupeng Pharmaceutical Co., Ltd., Hangzhou, China
24Newave Pharmaceutical Inc., Pleasanton, CA
25Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Minis-try of Education), Peking University Cancer Hospital & Institute, Beijing, China

Hyungwoo Cho, MD1*, Dok Hyun Yoon, MD, PhD2, Jason Yongsheng Chan3, Dajung Kim, MD4*, Haiwen Huang, MD5*, Qingqing Cai, PhD6, Tongyu Lin7*, Koji Kato, MD, PhD8, Udomsak Bunworasate, MD9*, Sen Mui Tan10*, Ka-Won Kang, MD, PhD11*, Jae-Yong Kwak12*, Tsai-Yun Chen13*, Jeong-Ok Lee, MD14, Seong Hyun Jeong, MD15*, Young Rok Do, MD, PhD16, Esther Chan17*, Hye Jin Kang18*, Hyun-Seok Uhm19*, Sung Yong Oh20*, Youngil Koh, MD, PhD21, Hyo Jung Kim22*, Se Hyung Kim, MD23*, Jong Ho Won24*, Young Hoon Park25*, Deok-Hwan Yang, MD, PhD26*, Soo Chin Ng, FRCP27, Jae-Cheol Jo, MD, PhD28 and Won Seog Kim, MD29*

1Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
2Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
3Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
4Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea, Republic of (South)
5National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
6Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
7Sichuan Cancer Hospital, Guangzhou, China
8Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan
9Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
10Department of Hematology, Ampang Hospital, Selangor, Malaysia
11Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea, Republic of (South)
12Department of Internal Medicine, Chonbuk National University Hospital, Jeonju, Korea, Republic of (South)
13National Cheng Kung University Hospital Clinical Trial Center, Tainan, Taiwan
14Department of Internal Medicine, Seoul National Univ. Bundang Hospital, Seongnam-Si, None, KOR
15Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea, Republic of (South)
16Department of Hemato-Oncology, Dongsan Medical Center, Keimyung University, Daegu, Korea, Republic of (South)
17Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
18Korea Cancer Center Hospital, Seoul, KOR
19National Cancer Center, Goyang, Korea, Republic of (South)
20Dong-A University Hospital, Busan, Korea, Republic of (South)
21Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
22Hallym University College of Medicine, Anyang, Korea, Republic of (South)
23Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon-Si, Gyeonggi-Do, KOR
24Department of Hematology-Oncology, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea, Republic of (South)
25Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of (South)
26Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Jeollanam-do, Korea, Republic of (South)
27Subang Jaya Medical Center, Petaling Jaya, Selangor, MYS
28Ulsan University Hospital, Ulsan, KOR
29Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Jacqueline F. Wang, MD1, Jihao Zhou, MD, PhD2,3*, Reema K. Tawfiq, MD4, Han W. Tun, MD4, Javier L. Munoz, MD, MS, MBA5, Jonas Paludo, MD3, Muhamad Alhaj Moustafa, M.D., M.S.4, Steven R. Hwang, MD3, Izel Okcu3*, Catherine S. Diefenbach, MD6, Jia Ruan, MD, PhD7, Peter Martin, MD7, Thomas M. Habermann, MD3, Thomas E. Witzig, MD8, Grzegorz S. Nowakowski, MD3 and Yucai Wang, MD, PhD3

1Department of Medicine, NYU Langone Health, New York, NY
2Department of Hematology, Shenzhen People’s Hospital, Shenzhen, China
3Division of Hematology, Mayo Clinic, Rochester, MN
4Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
5Division of Hematology and Medical Oncology, Myao Clininc, Phoenix, AZ
6Perlmutter Cancer Center at NYU Langone Health, New York, NY
7Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
8Division of Hematology, Mayo Clinic, Stabile 628, Rochester, MN

Kossi D Abalo, PhD1*, Trine Trab2*, Joachim Baech, MD3,4*, Sara Ekberg, PhD5*, Simon Pahnke, MD6*, Alexandra Albertsson-Lindblad, MD, PhD7*, Karin Ekstroem Smedby, MD8, Mats Jerkeman, MD, PhD9, Peter Brown, MD, PhD10,11*, Thomas Stauffer Larsen, MD, PhD12,13*, Kirsten Gronbaek, MD, PhD, PR14, Tarec Christoffer El-Galaly, MD, DMSc, Prof15 and Ingrid Glimelius, MD, Professor6

1Department of Immunology, Genetics and Pathology, Cancer Precision Medicine Unit, Uppsala University, Uppsala, Sweden
2Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark
3Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
4Department of Hematology, Clinical Cancer Research Unit, Aalborg University Hospital, Aalborg, Denmark
5Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institute, Stockholm, Sweden
6Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
7Division of Oncology, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden
8Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
9Division of Oncology, Department of Clinical Sciences Lund, Skåne University Hospital, Skane University Hospital, Lund, Skaane Laen, Sweden
10Copenhagen University Hospital, Rigshospitalet, Denmark, Copenhagen, Denmark
11Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
12Department of Hematology, Odense University Hospital, Odense, Denmark, Odense, Denmark
13Department of Clinical Research, University of Southern Denmark, Odense, Denmark
14Rigshospitalet, University of Copenhagen, Copenhagen N, Denmark
15Department of Hematology, Aalborg Hospital, Aalborg, Denmark

Stefano Luminari1, Michele Merli, MD2*, Sara Rattotti, MD3*, Maria Elena Nizzoli, MD4,5*, Vittoria Tarantino, MD6*, Simone Ferrero, MD7, Annalisa Talami, MD8*, Roberta Murru, MD9*, Marina Deodato, MD10*, Emanuele Cencini, MD11*, Francesca Re, MD12*, Carlo Visco, MD13*, Marcia Delamain, MD, PhD14*, Michele Spina, MD15*, Ombretta Annibali, MD16*, Alessandro Pulsoni, MD17*, Andrés José María Ferreri, MD18, Caterina Stelitano, MD19*, Elsa Pennese, MD20*, Emiliano Barbieri5*, Stefano Pozzi, MD4,5*, Luigi Marcheselli21*, Francesco Merli22*, Marco Paulli, MD23* and Luca Arcaini24*

1Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy
2Hematology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy
3Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
4Hematology Unit, Azienda USL- IRCCS di Reggio Emilia, Reggio Emilia, Italy
5Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
6Division of Hematology, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
7Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, TO, Italy
8Clinical and Experimental Medicine Doctorate School, Università degli Studi di Modena e Reggio Emilia, Reggio Emilia, Italy
9Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS G. Brotzu, Cagliari, Italy
10Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
11Division of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy
12Division of Hematology, Azienda Ospedaliera Universitaria di Parma, Parma, Italy
13Hematology and Bone Marrow Transplant Unit, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy
14Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil
15Division of Medical Oncology, IRCCS Centro Di Riferimento Oncologico, Aviano, Italy
16Division of Hematology, Stem Cell Transplantation,, Fondazione Policlinico Universitario Campus Bio Medico, Roma, Italy
17Division of Hematology, Sapienza University – Polo Pontino, Department of Translational and Precision Medicine, S.M. Goretti Hospital, Latina, Italy
18Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
19Division of Hematology, Grande Ospedale Metropolitano, Bianchi Melacrino Morelli, Reggio Calabria, Italy
20Centro diagnosi e terapia dei linfomi, Presidio Ospedaliero Spirito Santo, Pescara, Italy
21Fondazione Italiana Linfomi, Clinical Trial Office, Modena, Italy
22Hematology Department, AZIENDA USL-IRCCS DI REGGIO EMILIA, Reggio Emilia, Italy
23Pathology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
24Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Hassan Ali, MD, MBBS1*, Shubham Agrawal, MBBS2, Satya R Durugu, MD1*, Shrishti Sinha, MD3*, Shammas Bajwa, MD4*, Umair Bajwa, MBBS5*, Rajesh Thirumaran, MD6* and Krishna Desai1*

1Mercy Catholic Medical Center, Philadelphia, PA
2Masonic Cancer Center, University of Minnesota, Minneapolis, MN
3Richmond University Medical Center, Staten ISland, NY
4Internal Medicine Department, Oklahoma University Medical Center, Oklahoma City, OK
5Services Institute of Medical Sciences, Lahore, Pakistan
6Mercy Catholic Medical Center, Darby, PA

Sarah Mant1*, Georgina Naylor1*, Nicola Crosbie1*, Sree Aroori2*, Mark J Bishton, PhD, MBChB3, Kristian Bowles, MBBS, PhD4, Safia Dawi5*, Toby A. Eyre6*, Wendy Ingram2*, Abigail Martin1*, Christopher McNamara, MD7*, Melanie Oates8*, Andrew Pettitt, MD, PhD8*, Claire Scully2*, Brian Wainman2*, Mark Warner2*, Simon Rule, MD9* and David John Lewis, MD1*

1University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
2Plymouth University, Peninsula Clinical Trials Unit, Plymouth, United Kingdom
3Nottingham University Hospitals NHS Trust, Nottingham, UK, United Kingdom
4Norfolk and Norwich University Hospital, Norwich, United Kingdom
5Hull University Teaching Trust, Hull, United Kingdom
6Department of Clinical Haematology, Oxford University Hospitals NHS Trust, Old Road, United Kingdom
7University College London Hospitals NHS Foundation Trust, London, United Kingdom
8Department of Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
9Executive Director, Haematology R&D, AstraZeneca, Cambridge, United Kingdom

Julia Bannatyne Undabeitia1*, Elia Barrio2*, Ruben Fernandez Alvarez, MD3*, Anabel Teruel4*, María José Terol5*, Sheila Bodelon6*, Eduardo Rios Herranz, MD7*, Victor Marco8*, Fernando Carnicero9*, Leonor Perez10*, Angel Mayorales11*, Iñigo Romon, MD, PhD12*, Sara Fernandez-Luis, MD13*, Enrique M. Ocio13 and Arancha Bermúdez14,15*

1Hospital Universitario Marques de Valdecilla (IDIVAL), Santander, Spain
2Hospital Universitario San Pedro, Logroño, Spain
3Hospital Universitario de Cabueñes, Asturias, Spain
4Hospital Clínico Valencia, VALENCIA, ESP
5Hospital Clínico Universitario INCLIVA, University of Valencia, Valencia, Spain
6Hospital del Bierzo, Leon, Spain
7Hematology Department, University Hospital Ntra. Sra de Valme, Seville, Spain
8Hospital Universitario San Jorge, Huesca, Spain
9Hospital San Pedro de Alcántara, Caceres, ESP
10Complejo Hospitalario Universitario Insular Materno Infantil, Gran Canaria, Spain
11Hospital General Universitario de Ciudad Real., Ciudad Real, Spain
12Hospital Universitario Marques de Valdecilla (IDIVAL), Santander, Cantabria, ESP
13Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
14Department of Hematology, Hospital Universitario Marqués de Valdecilla, Cantabria, Spain
15Hospital Marques de Valdecilla (IDIVAL), Santander, Spain

Oboseh John Ogedegbe, MD1*, Asfand Yar Cheema, MD2*, Ahmed Bashir Sukhera, MD3*, Serhan Unlu, MD4, Jorge Rodriguez Vazquez, MD3*, Gloria Erazo, MD3* and Godfrey Tabowei5*

1Trinity Health Ann Arbor Hospital, Ypsilanti, MI
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Department of Internal Medicine, Texas Tech University Health Sciences Center at the Permian Basin, Odessa, TX
4Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
5Texas Tech University Health Science, Permian Basin, Odessa, TX

Adam J. Olszewski, MD1,2, Matthew Matasar, MD, MS3, Scott F Huntington4, Thomas Ollila, MD1,2, Ari Pelcovits, MD1,5, Yun Kyoung Tiger, MD, PhD6, John L. Reagan, MD7, Anna Dorota Chorzalska, PhD1*, John Morgan, PhD1*, Makayla R Pardo1, Jessica McMahon, BSN2*, Stephen Donnelly, BS2*, Caylee Carmody, BS, MHS2*, Jeannine Margolis, B.Sc.8*, Charles Milrod, MD1 and Patrycja M. Dubielecka, PhD1,9

1Brown University, Providence, RI
2Lifespan Cancer Institute, Rhode Island Hospital, Providence, RI
3Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
4Yale School of Medicine, New Haven, CT
5Rhode Island Hospital, Providence, RI
6Division of Hematology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
7Brown University Health Cancer Insitute, Warren Alpert Medical School of Brown University, Providence, RI
8Brown University Oncology Research Group, Providence, RI
9Dubielecka Lab, Rhode Island Hospital, Providence, RI

Nancy L. Bartlett, MD1, Laurie H. H. Sehn, MD2, Sarit E. Assouline, MD3, Pratyush Giri, MBBS4*, John Kuruvilla, MD, FRCPC5, Stephen J. Schuster6*, Sung-Soo Yoon, M.D., Ph.D.7, Keith Fay8*, Georg Hess, MD9*, Martin Dreyling, MD10, Norma C. Gutierrez11*, Eva Cybulski12*, Antonia Kwan12*, Elicia Penuel12, Samuel Tracy12*, Denison Kuruvilla12*, Joseph Chen12*, Volker Wiebking12*, Michael C. Wei12* and L. Elizabeth Budde13

1Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
2BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
3Jewish General Hospital, Montreal, QC, Canada
4Royal Adelaide Hospital, Adelaide, Australia
5Princess Margaret Cancer Centre, Toronto, ON, Canada
6Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
7Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea, Republic of (South)
8St Vincent's Hospital and Royal North Shore Hospital, Sydney, Australia
9University Cancer Center Mainz, University Medical School of the Johannes Gutenberg-University, Mainz, Germany
10Ludwig-Maximilians-University Hospital Munich, Munich, Germany
11Institute of Biomedical Research of Salamanca (IBSAL), University Hospital, Salamanca, Spain
12Genentech, Inc., South San Francisco, CA
13City of Hope National Medical Center, Duarte, CA

L. Elizabeth Budde1, Matthew Matasar, MD, MS2, Laurie H. H. Sehn, MD3, Sarit E. Assouline, MD4, John Kuruvilla, MD, FRCPC5, Ian W. Flinn, MD, PhD6, Sung-Soo Yoon, M.D., Ph.D.7, Francesc Bosch8*, Daniel Greenwald9*, Norma C. Gutierrez10*, Dimitrios Tzachanis11*, Paula Marlton12*, Delaney McGuirt13*, Shen Yin13*, Michael C. Wei13*, Antonia Kwan13*, Samuel Tracy13*, Elicia Penuel13 and Nancy L. Bartlett, MD14

1City of Hope National Medical Center, Duarte, CA
2Memorial Sloan Kettering Cancer Center, New York, NY
3BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
4Jewish General Hospital, Montreal, QC, Canada
5Princess Margaret Cancer Centre, Toronto, ON, Canada
6Tennessee Oncology, Nashville, TN
7Center for Medical Innovation, Seoul National University Hospital, Seoul, Korea, Republic of (South)
8University Hospital Vall d’Hebron and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
9University of California, Los Angeles Health Hematology Oncology, Santa Barbara, CA
10Institute of Biomedical Research of Salamanca (IBSAL), University Hospital, Salamanca, Spain
11Moores Cancer Center, University of California San Diego, La Jolla, CA
12Princess Alexandra Hospital and University of Queensland, Brisbane, Australia
13Genentech, Inc., South San Francisco, CA
14Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO

Jorge J. Castillo, MD1, Shayna R Sarosiek1, Andrew R. Branagan, MD2, Gottfried von Keudell, MD, PhD3, Catherine A. Flynn, NP1*, Andres Ramirez-Gamero, MD1*, Nina S Budano1*, Alexandra N. Eurell1*, Kirsten Meid, MPH1*, Maria Luisa Guerrera, MD1, Amanda Kofides, BA1*, Shirong Liu, MD, PhD1, Xia Liu, MD1*, Kris Richardson, PhD1*, Nickolas Tsakmaklis1*, Christopher J Patterson, MPH, MBA1*, Zachary R Hunter, PhD1 and Steven P. Treon, MD, PhD, FRCP4

1Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
2Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA
3Beth Israel Deaconess Medical Center, Boston, MA
4Dana-Farber Cancer Institute, Dana-Farber Cancer Institute, Inc., Boston, MA

Xiong Wenjie, MD1*, Yuting Yan, MD2*, Tingyu Wang2*, Weiwei Sui, MD3*, Ying Yu1*, Tengteng Yu2*, Rui Lyu, MD1*, Wei Liu, MD1*, Huimin Liu4*, Gang An1*, Wenyang Huang, MD3*, Dehui Zou1*, Lu-Gui Qiu, M.D.1 and Shuhua Yi, MD3*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China

Constantine S. Tam, MD, MBBS1, Anna Maria Frustaci, MD2*, Fontanet Bijou, MD3, Pier Luigi Zinzani, MD, PhD4, John F. Seymour, MBBS, PhD5, Masa Lasica, MBBS, BMedSci, FRACP, FRCPA6*, Herbert A. Eradat, MD7, Victor T.G. Lin8*, Maan Alwan9*, Irina Mocanu, MD10*, Xiangmei Chen11*, Kunthel By, PhD12*, Shannon Fabre12*, Daniel O. Persky, MD12, Amit Agarwal12* and Chan Y. Cheah, MBBS DMSc13,14,15

1Alfred Hospital and Monash University, Melbourne, VIC, Australia
2ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
3Institut Bergonié, Bordeaux, France
4Institute of Hematology "Seràgnoli", University of Bologna, Bologne, Italy
5Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
6St Vincent’s Hospital, Melbourne, Australia
7David Geffen School of Medicine at UCLA, Los Angeles, CA
8Mary Bird Perkins Cancer Center, Baton Rouge, LA
9Perth Blood Institute, West Perth, Western Australia, Australia
10Institute of Oncology, ARENSIA Exploratory Medicine, Düsseldorf, Germany
11BeiGene (Shanghai) Co, Ltd, Shanghai, China
12BeiGene USA, Inc, San Mateo, CA
13Linear Clinical Research, Nedlands, Western Australia, Australia
14Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
15Medical School, University of Western Australia, Perth, Western Australia, Australia

Matthew Matasar, MD, MS1, David Tucker2, Tae Min Kim, MD, PhD3*, Stefano Luminari4, Yuan Cheng5*, Jingjin Li5*, Saleem Shariff6*, Hesham Mohamed5, Srikanth Ambati5 and Aafia Chaudhry5

1Division of Blood Disorders, Rutgers Cancer Institute and RWJBarnabas Health, New Brunswick, NJ
2Haematology Department, Royal Cornwall Hospital, Truro, United Kingdom
3Seoul National University Hospital, Seoul, Korea, Republic of (South)
4Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy
5Regeneron Pharmaceuticals, Inc., Tarrytown, NY
6Regeneron UK Ltd, Uxbridge, United Kingdom

Suheil Albert Atallah-Yunes, MD1, Matthew James Rees, MD1, Javier Munoz, MD2*, Jonas Paludo, MD1, Muhamad Alhaj Moustafa, M.D., M.S.3, Arushi Khurana, MBBS1, Jose C. Villasboas Bisneto, MD4, Allison C. Rosenthal, DO5, Januario E. Castro, MD6, Madiha Iqbal, MD7, Mohamed A. Kharfan-Dabaja, MD, MBA8, N. Nora Bennani, MD1, Paul J. Hampel, MD1, Urshila Durani, MD, MPH1, Patrick B. Johnston, MD, PhD1*, Andre De Menezes Silva Corraes, MD1*, Luis Porrata, MD1, Stephen M. Ansell, MD, PhD1, Yi Lin, MD, PhD1 and Yucai Wang, MD, PhD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Phoenix, AZ
3Division of Hematology, Mayo Clinic, Jacksonville, FL
4Mayo Clinic, Rochester, MN
5Division of Hematology/Oncology Mayo Clinic, Phoenix, AZ
6Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
7Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
8Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL

Carla Casulo, MD1, Melissa C. Larson, MS2*, Jonathan R Day, MD, PharmD3, Urshila Durani, MD, MPH4, Mazie Tsang, MD5, Jonathan W. Friedberg, MD6, Grzegorz S. Nowakowski, MD7, Jean L. Koff, MD, MSc8, Dai Chihara, MD, PhD9, Richard Burack, MD, PhD10, Thomas M. Habermann, MD7, Loretta Nastoupil9*, Izidore S. Lossos, MD11, Peter Martin, MD12, Matthew Holets13*, Brad S. Kahl, MD14, Jonathan J. Cohen, MD15, James R. Cerhan, MD, PhD16, Christopher R. Flowers, MD, MS9, Brian K. Link, MD17* and Matthew J. Maurer, DSc18

1James P. Wilmot Cancer Center, Rochester, NY
2Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, MN
3Department of Medicine, Mayo Clinic, Rochester, MN
4Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
5Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ
6Wilmot Cancer Center, University of Rochester, Rochester, NY
7Division of Hematology, Mayo Clinic, Rochester, MN
8Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
9Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
10Pathology and Laboratory Medicine, University of Rochester, Rochester, NY
11Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
12Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
13Mayo Clinic, Rochester, MN
14Department of Medicine, Washington University School of Medicine, St. Louis, MO
15Department of Internal Medicine, Division of Hematology, University of Miami Hospital - Jackson Memorial Hospital, Miami, FL
16Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
17Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
18Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

Yizhen Liu, MD, PhD1*, Lingyu Liu2*, Chuanxu Liu, MD, PhD1*, Wenhao Zhang1*, Shiyu Jiang1*, Qunling Zhang1*, Fangfang Lyu1*, Xiaojian Liu1*, Junning Cao1, Xuejun Ma1* and Rong Tao1*

1Fudan University Shanghai Cancer Center, Shanghai, China
2Fudan University Cancer Hospital Xiamen Hospital, Xiamen, China

Ryan Low, BSc, MBBS, MRCP1*, Andrew Warden2*, Michelle Postek3*, Peter Denardis3*, Charalampia Kyriakou, MD, PhD4, Adam J. Olszewski, MD5, Marie José Kersten6*, Josephine M.I. Vos7*, Sheeba K. Thomas, MD8, Shirley D'Sa, FRCP FRCPath MD(Res)9*, Newton Guerin3*, Carl Harrington3*, Judith Trotman, FRACP10 and Ibrahim Tohidi-Esfahani, MBBS, FRACP, FRCPA10

1Concord Repatriation General Hospital, University of Sydney, London, ENG, United Kingdom
2Wmozzies, Australian Patient Support Group For WM, Concord, AUS
3International Waldenström's Macroglobulinemia Foundation, Sarasota, FL
4UCLH Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom
5Brown University, Providence, RI
6Cancer Center Amsterdam, Amsterdam, Netherlands
7Amsterdam UMC, University of Amsterdam & Sanquin, Amsterdam, Netherlands
8Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9University College London Hospitals NHS Foundation Trust, London, United Kingdom
10Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia

Ahmed Sawas, MD1,2, Niquelle Brown Wadé3* and James Roose3*

1Flatiron Health Inc., New York, NY
2Lymphoma Program, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
3Flatiron Health, New York, NY

Yuhan Gao1*, Siyuan Li2*, Yue Dang2*, Minghui Duan2*, Jian Li, MD2 and Lu Zhang, MD1*

1Department of Hematology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
2Department of Hematology, Peking Union Medical College Hospital, Beijing, China

Benoit Tessoulin, MD, PhD1,2*, Franck Morschhauser, MD, PhD3, David Chiron, PhD4*, Krimo Bouabdallah, MD5*, Guillaume Cartron, MD, PhD6*, Cedric Rossi, MD, PhD7, Caroline Milin, MD, PhD8*, Ludovic Fouillet, MD9*, Charles Herbaux, MD, PhD10*, Emmanuelle Tchernonog11*, Rory McCulloch, FRCPath, MRCP, MBBS12*, Thomas Gastinne, MD13*, Mary B. Callanan, PhD14* and Steven Le Gouill, MD, PhD15

1CRCI2NA, Integrated Research Center in Immunology and Oncology, Nantes University, Nantes, France
2Department of hematology, Nantes university hospital, Nantes, France
3Centre Hospitalier Régional Universitaire de Lille, Lille, France
4CRCI²NA - Nantes - Angers Cancer and Immunology Research Center, Nantes, NY, France
5Bordeaux university hospital, Haut-Leveque, Department of hematology, Bordeaux, France
6Centre Hospitalier Universitaire de Montpellier, Montpellier, France
7CHU Dijon, DIJON, France
8Department of Nuclear Medicine, University Hospital of Nantes, Nantes, France
9Hematology department, CHU, Saint-Etienne, France
10Department of Hematology, Montpellier university hospital, Montpellier, France
11Hematology Department, CHU Montpellier, Montpellier Cedex 5, France
12Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom
13Centre Hospitalier Universitaire de Nantes, Nantes, France
14CHU de Dijon, Université de Bourgogne, Dijon, France
15Institut Curie, Saint-Cloud, France

Ángel Serna, MD1*, Marc Bosch1*, Victor Navarro Garces, BSc2*, Patricia Lopez Pereira3*, David Quintela4*, Juan-Manuel Sancho, MD, PhD4*, Adolfo Jesús Sáez Marín, MD5*, Ana Jiménez Ubieto6*, Alberto López7*, Raul Cordoba, MD, PhD8, Maria Cerdá9*, Beatriz De La Cruz10*, Samuel Romero11*, Ainara Ferrero12*, Tomas Garcia Cerecedo12*, Teresa Villalobos13*, Andrea Rivero, MD14*, Cristina García, MD15*, Ana Marín Niebla16*, Gloria Iacoboni, MD15*, Francesc Bosch, MD, PhD17 and Pau Abrisqueta Costa, MD, PhD17*

1Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
2Statistics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
3Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, HOSPITALET, Spain
4ICO-IJC-Hospital Germans Trias i Pujol, Barcelona, Spain
5Servicio de Hematología, Hospital 12 de Octubre, Madrid, Madrid, Spain
6Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
7Hematology Department, Fundación Jiménez Díaz, Madrid, Spain
8Department of Hematology, Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
9ICO-Hospital Josep Trueta, Gerona, Spain
10Hematology Department, Hospital Universitario La Paz, Madrid, Spain
11Hospital Universitari i Politècnic La Fe, Valencia, Spain
12University Hospital Arnau de Vilanova, Lleida, Spain
13Hematology Department, Hospital Mutua de Terrassa, Terrassa, Spain
14Department of Hematology, Hospital Clínic, Barcelona, Barcelona, Spain
15Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
16Department of Hematology University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
17Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Yeokyeong Shin1*, Jaewon Hyung, MD2*, Hyungwoo Cho2*, Shin Kim2*, Chan-Sik Park, MD, PhD3*, Heounjeong Go3*, In Hye Song3*, Jin-Sook Ryu4*, Sang-wook Lee5* and Dok Hyun Yoon, MD, PhD2

1Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
2Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
3Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
4Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
5Depertment of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Sebastian Giebel, MD, PhD1*, Anna Czyz2*, Iwona Hus, MD3*, Lidia Gil, MD, PhD4, Krzysztof Giannopoulos, MD, PhD5*, Joanna Romejko-Jarosinska6*, Maciej Majcherek7*, Agnieszka Szeremet8*, Anna Wache9*, Paulina Kwasnik10*, Wlodzimierz Mendrek11* and Wojciech Jurczak, MD, PhD12

1Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
2Deaprtment of Hematology, Medical University of Wroclaw, Wroclaw, Poland
3ul. Wołoska 137, The National Institute of Medicine of the Ministry of Interior and Administration, Warszawa, Poland
4Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland
5Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
6Maria Sklodowska-Curie Institute - Oncology Centre, Warsaw, Poland
7Medical University of Wroclaw, Wroclaw, Poland
8Wroclaw Medical University, Wroclaw, Poland
9Poznan University of Medical Sciences, Poznan, Poland
10Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland
11Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
12Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Malopolskie, Poland

Anubhuti Sharma, MD1*, Arundhati Sharma2*, Simranpreet Singh Daid, MBBS3*, Vagisha Sharma4*, Akriti Agrawal, MD5*, Adishwar Rao, MD5* and Joyson Poulose, MD6

1Guthrie/Robert Packer Hospital, Sayre, PA
2MAYO clinic, ARIZONA, AZ
3PIMS, JALANDHAR, Abohar, India
4GUTHRIE/ROBERT PACKER HOSPITAL, New Delhi, India
5GUTHRIE/ROBERT PACKER HOSPITAL, Sayre
6Guthrie Robert Packer Hospital, Sayre, PA

Hui-Peng Lee, MD1*, Stephen S. Opat, MBBS, FRACP, FRCPA2, John Hrom3*, David Kliman, MBBS, FRACP, FRCPA4*, Paula Marlton5*, Peng Liu, MD6, Chenmu Du7*, Amber Lussier8*, Jun Zhang8*, Haiyi Guo9* and Steven P. Treon, MD, PhD, FRCP10

1Flinders Medical Centre, Adelaide, Australia
2Lymphoma Research Group, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia
3Hattiesburg Clinic, Hattiesburg, MS
4GenesisCare North Shore, St Leonards, NSW, Australia
5Princess Alexandra Hospital and University of Queensland, Brisbane, QLD, Australia
6Affiliated Zhongshan Hospital of Fudan University, Shanghai, China
7BeiGene (Beijing) Co, Ltd, Beijing, China
8BeiGene USA, Inc, San Mateo, CA
9BeiGene (Shanghai) Co, Ltd, Shanghai, China
10Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Carrie I Ho, MD1,2, Mengyang Di, MD, PhD1,2, Ryan C Lynch, MD1,2, Christina Poh, MD1,2, Vikram Raghunathan, MD1,2*, Mazyar Shadman, MD, MPH1,2, Stephen D. Smith, MD1,2, Brian G. Till, MD2,3, Paul S Martin, MD1,2, Chaitra S. Ujjani, MD1,2 and Ajay K. Gopal, MD1,2

1Fred Hutchinson Cancer Center, Seattle, WA
2Division of Hematology and Oncology, University of Washington, Seattle, WA
3Fred Hutchinson Cancer Center, University of Washington, Seattle, WA

Anne W Beaven, MD1, Susan M. Geyer, PhD2, Jonathon B. Cohen, MD, MS3, Tycel Phillips, MD4*, Travis Dockter2*, Priyanka A. Pophali, MD5, Gita Thanarajasingam, MD6, Gina L. Mazza, PhD7*, Alvaro J Alencar, MD8, Shira N. Dinner, MD9, Eric D. Hsi, MD10, Meng Welliver, MD11*, Daniel Nikcevich, MD, PhD12, Brad S. Kahl, MD13, Jonathan W. Friedberg, MD14, Nancy L. Bartlett, MD15 and John P. Leonard, MD16

1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
2Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN
3Winship Cancer Institute, Emory University, Atlanta, GA
4City of Hope, Duarte, CA
5Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI
6Division of Hematology, Mayo Clinic, Rochester, MN
7Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ
8Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami Beach, FL
9Alliance Protocol Operations Office, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
10Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
11Mayo Clinic, Rochester, MN
12Essentia Health Cancer Center, Duluth, MN
13Department of Medicine, Washington University School of Medicine, St. Louis, MO
14Wilmot Cancer Center, University of Rochester, Rochester, NY
15Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
16Weill Cornell Medicine, New York, NY

*signifies non-member of ASH